Financhill
Back

Regenxbio Vs. Vertex Pharmaceuticals Industry Stock Comparison

Sell
30

RGNX
Regenxbio

Last Price:
9.31
Seasonality Move:
0.61%
Buy
62

VRTX
Vertex Pharmaceuticals

Last Price:
492.51
Seasonality Move:
6.39%
Sell
30
Regenxbio (RGNX) is a Sell

Is Regenxbio a Buy, Sell or Hold?

  • The current Regenxbio [RGNX] share price is $8.92. The Score for RGNX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • RGNX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Vertex Pharmaceuticals (VRTX) is a Buy

Is Vertex Pharmaceuticals a Buy, Sell or Hold?

  • The current Vertex Pharmaceuticals [VRTX] share price is $499.88. The Score for VRTX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • VRTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RGNX Stock Price Chart

What is Regenxbio's stock price today?

  • The Regenxbio share price today is $8.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGNX is experiencing buying pressure, which is a positive indicator for future bullish movement.

VRTX Stock Price Chart

What is Vertex Pharmaceuticals's stock price today?

  • The Vertex Pharmaceuticals share price today is $499.88
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

RGNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.54 Sell
Relative Strength Index (14 RSI): 37.75 Sell
Chaikin Money Flow: 270845 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.98 - 10.22) Sell
Bollinger Bands (100): (10.11 - 12.95) Sell

VRTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.54 Buy
Relative Strength Index (14 RSI): 64.53 Buy
Chaikin Money Flow: 1300283 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (462.01 - 484.31) Buy
Bollinger Bands (100): (466.42 - 489.1) Buy

RGNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.96 Sell
20-day SMA: 9.56 Sell
50-day SMA: 10.68 Sell
200-day SMA: 14.43 Sell
8-day EMA: 9.02 Sell
20-day EMA: 9.52 Sell
50-day EMA: 10.47 Sell
200-day EMA: 13.59 Sell

VRTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 477.49 Buy
20-day SMA: 476.96 Buy
50-day SMA: 474.11 Buy
200-day SMA: 450.92 Buy
8-day EMA: 479.73 Buy
20-day EMA: 476.22 Buy
50-day EMA: 474.52 Buy
200-day EMA: 449.21 Buy

Regenxbio Earnings Growth & RGNX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.00 per share, and an increase next year of $3.77 per share.

Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.70 per share, a decrease next quarter of $0.00 per share, a decrease this year of $14.60 per share, and an increase next year of $18.34 per share.

Regenxbio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Vertex Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):